WO2009103427A3 - Utilisation de 3-(4-hydroxy-3-méthoxyphényl)-1(4-hydroxyphényl)- propane-1-one contre l'hyperpigmentation - Google Patents

Utilisation de 3-(4-hydroxy-3-méthoxyphényl)-1(4-hydroxyphényl)- propane-1-one contre l'hyperpigmentation Download PDF

Info

Publication number
WO2009103427A3
WO2009103427A3 PCT/EP2009/000785 EP2009000785W WO2009103427A3 WO 2009103427 A3 WO2009103427 A3 WO 2009103427A3 EP 2009000785 W EP2009000785 W EP 2009000785W WO 2009103427 A3 WO2009103427 A3 WO 2009103427A3
Authority
WO
WIPO (PCT)
Prior art keywords
methoxyphenyl
hydroxyphenyl
propane
hydroxy
hyperpigmentation
Prior art date
Application number
PCT/EP2009/000785
Other languages
German (de)
English (en)
Other versions
WO2009103427A2 (fr
Inventor
Stefanie Knaupmeier
Christoph Smuda
Ludger Kolbe
Julia Eckert
Gitta Neufang
Nils Peters
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of WO2009103427A2 publication Critical patent/WO2009103427A2/fr
Publication of WO2009103427A3 publication Critical patent/WO2009103427A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)

Abstract

Utilisation de 3-(4-hydroxy-3-méthoxyphényl)-1-(4-hydroxyphényl)-propane-1-onedans des préparations cosmétiques ou dermatologiques pour le traitement et la prophylaxie d'états cutanés post-inflammatoires.
PCT/EP2009/000785 2008-02-18 2009-02-05 Utilisation de 3-(4-hydroxy-3-méthoxyphényl)-1(4-hydroxyphényl)- propane-1-one contre l'hyperpigmentation WO2009103427A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008009799.3A DE102008009799B4 (de) 2008-02-18 2008-02-18 Verwendung von 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on gegen Hyperpigmentierung
DE102008009799.3 2008-02-18

Publications (2)

Publication Number Publication Date
WO2009103427A2 WO2009103427A2 (fr) 2009-08-27
WO2009103427A3 true WO2009103427A3 (fr) 2009-11-19

Family

ID=40874094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/000785 WO2009103427A2 (fr) 2008-02-18 2009-02-05 Utilisation de 3-(4-hydroxy-3-méthoxyphényl)-1(4-hydroxyphényl)- propane-1-one contre l'hyperpigmentation

Country Status (3)

Country Link
CN (1) CN101524315A (fr)
DE (1) DE102008009799B4 (fr)
WO (1) WO2009103427A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2974300B1 (fr) * 2011-04-19 2013-05-10 Inneov Lab Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11236328A (ja) * 1997-12-16 1999-08-31 Mitsui Chem Inc ハイドロカルコン誘導体および／またはカルコン誘導体を有効成分とする化粧料
WO2009013168A1 (fr) * 2007-07-25 2009-01-29 Symrise Gmbh & Co. Kg 3-(4-hydroxy-3-méthoxyphényl)-1-(4-hydroxyphényl)-1-propanone et son utilisation en tant qu'antioxydant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308282C2 (de) 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
EP1818060A1 (fr) * 2005-11-23 2007-08-15 ARTSANA S.p.A. Composition cosmétique comprenant d'extraits de Fadogia ancylantha
EP1977655B1 (fr) * 2007-03-29 2011-05-18 Symrise AG Compositions d'aromes d'alcamides comprenant de l'hespérétine et/ou des 4-hydroxydihydrochalcones et leurs sels destinées à renforcer les impressions sensorielles sucrées

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11236328A (ja) * 1997-12-16 1999-08-31 Mitsui Chem Inc ハイドロカルコン誘導体および／またはカルコン誘導体を有効成分とする化粧料
WO2009013168A1 (fr) * 2007-07-25 2009-01-29 Symrise Gmbh & Co. Kg 3-(4-hydroxy-3-méthoxyphényl)-1-(4-hydroxyphényl)-1-propanone et son utilisation en tant qu'antioxydant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KHATIB S ET AL: "Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, vol. 13, no. 2, 17 January 2005 (2005-01-17), pages 433 - 441, XP004681527, ISSN: 0968-0896 *
LIN ET AL: "Constituents from the Formosan apple reduce tyrosinase activity in human epidermal melanocytes", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 68, no. 8, 6 April 2007 (2007-04-06), pages 1189 - 1199, XP022023215, ISSN: 0031-9422 *

Also Published As

Publication number Publication date
WO2009103427A2 (fr) 2009-08-27
DE102008009799A1 (de) 2009-08-20
DE102008009799B4 (de) 2017-07-20
CN101524315A (zh) 2009-09-09

Similar Documents

Publication Publication Date Title
WO2006087759A3 (fr) Composition pharmaceutique comprenant de la curcumine et du resveratrol et leurs utilisations dans le domaine medical
MX2009011743A (es) Composiciones despigmentantes dermatologicas y cosmeticas, sus procedimientos de preparacion, y sus usos.
MX299318B (es) Composiciones cosmeticas topicas para aclarar la piel, y metodos de uso de las mismas.
EP2234594A4 (fr) Compositions et procédés dermatologiques à base d'extrait de tramètes
WO2010083368A3 (fr) Compositions de séquestration du calcium et procédés de traitement des troubles et des affections de la pigmentation de la peau
EP2295028A4 (fr) Préparation destinée à prévenir ou à améliorer les rides, devant être prise par voie orale, par injection ou par application cutanée externe, et procédé cosmétique
WO2008137633A3 (fr) Procédés de modulation de voies de signalisation homéostatique cellulaires et survie cellulaire
HK1150757A1 (en) Skin whitening agent and external preparation for the skin
HK1149322A1 (en) Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
EP2063859A4 (fr) Composition cosmétique pour le traitement de la peau et procédés correspondants
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
WO2009141541A3 (fr) Utilisation d' inhibiteurs de kif13a et d ' ap-1 pour inhiber la melanogenese
WO2008070859A3 (fr) Traitement d'affections cutanées par dickkopf1 (dkk1)
HK1141454A1 (en) A cosmetic composition for skin whitening comprising the extract of magnolia sieboldii as active ingredient
GB0719202D0 (en) Compositions and methods for the skin and hair
ZA201104079B (en) Therapeutic,dietary,or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3,and compositions containing these compounds
EP2274411A4 (fr) Compositions de xanthohumol et procédés de traitement des maladies ou des affections cutanées
WO2010015965A3 (fr) Procédés et compositions de traitement d'un dommage neuronal et de modulation de canaux potentiels de récepteurs transitoires
IL185775A0 (en) Pomegranate-derived products for the treatment of skin sores and lesions
EP2120994A4 (fr) Procédés et compositions de traitement de troubles hypoglycémiques
PT2331057T (pt) Composições e métodos para modulação da pigmentação da pele
WO2008033353A9 (fr) Traitement au laser de lésions pigmentées de la peau
EP2224937A4 (fr) Composition de prévention et de traitement de maladies métaboliques comprenant un extrait de lysimachiae foenum-graeci herba
EP2214634A4 (fr) Hydratant pour la peau, promoteur de la circulation sanguine, et préparations externes pour la peau contenant l'hydratant pour la peau et le promoteur de la circulation sanguine
WO2009103427A3 (fr) Utilisation de 3-(4-hydroxy-3-méthoxyphényl)-1(4-hydroxyphényl)- propane-1-one contre l'hyperpigmentation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09712301

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09712301

Country of ref document: EP

Kind code of ref document: A2